Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

HenriHenri David, 75, has lived for 42 years with Parkinson’s disease. There is no known cure for the ... Over the years, ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Popular drugs like Ozempic and Wegovy are known for dramatic weight loss, but they also can potentially help with substance ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Generics can help lower costs, but the savings don't always make their way to patients THURSDAY, Oct. 31, 2024 (HealthDay News) -- A person battling multiple sclerosis spent an average of $750 in ...